2 "Cheap" Funds I Won't Buy in 2026 (and a 7.5% Payer I'd Double Down On)

Two recent closed-end fund IPOs exposed large, persistent discounts: Bluerock Private Real Estate (BPRE) plunged to about a 40% discount on listing and remains roughly 35% below NAV, while FS Specialty Lending (FSSL) trades at a 23.6% discount with the market implying $13.95 per share versus management's $18.25 and offering a 12% yield. The piece warns these post-listing markdowns can persist and can signal lower-than-expected cash flows and potential dividend cuts for newly listed funds, while contrasting that risk with an established CEF, Virtus Equity & Convertible Income (NIE), which yields ~8%, trades at a ~9.7% discount and has produced roughly a 46% total return since a March 2022 recommendation, illustrating a more tradeable discount/arbitrage opportunity.

Analysis

Market structure: The primary winners are managers and retail sellers who monetized illiquid holdings via IPOs (FSSL, BPRE sponsors) and buyers of established, liquid CEFs (e.g., NIE) who can capture yield + discount compression. Losers are IPO-era shareholders facing immediate NAV haircuts (BPRE ~-35%, FSSL ~-23.6%) and short-term liquidity providers who mispriced private/BDC assets. Expect persistent structural discounts for newly listed illiquid-asset CEFs absent demonstrable NAV transparency or distribution coverage improvements over 6–12 months.

Risk assessment: Tail risks include sudden distribution cuts (if realized loan losses exceed 10–15% of expected cashflow), forced redemptions or gating policy reversals, and regulatory scrutiny of IPO conversions (SEC inquiries within 3–9 months). Near-term (days–weeks) volatility will track flows and headlines; medium-term (3–12 months) outcomes depend on quarterlies showing realized income vs. accruals; long-term (>12 months) discount normalization is uncertain and manager-dependent. Hidden dependencies include sponsor fee structures, related-party transactions, and illiquid asset mark methodology that can keep discounts wide despite stable headline yields.

Trade implications: Favor long exposure to established liquid equity/CID CEFs with consistent coverage (e.g., NIE) and short or avoid newly listed private-asset CEFs (FSSL, BPRE) until discounts compress <10–15% or distribution coverage >1.0 for two consecutive quarters. Cross-asset: widening CEF discounts increase demand for corporate credit hedges — buy IG protection sparingly and widen high-yield spreads if macro deteriorates; expect modest upward pressure on term premium if retail flows exit illiquid funds.

Contrarian angles: Consensus assumes new-listing discounts eventually close — history shows many persist for years absent sponsor interventions. A mispricing opportunity exists to buy proven CEFs when discounts spike >300–500bp and to sell when <700bp; conversely, shorting new IPO CEFs is underpriced given opaque NAVs. Catalysts to reverse trends: transparent monthly NAV reporting, sponsor NAV support or accretive buybacks, or rate cuts within 6–9 months improving credit spreads and loan recoveries.

Key Decisions for Investors

• Establish a 2–3% long position in NIE (Virtus Equity & Convertible Income, ticker NIE) sized to portfolio risk; target a 15–25% total return or sell when discount narrows below 7% or within 9–12 months, whichever comes first.
• Avoid new-listing private-asset CEFs and consider a small tactical short (0.5–1% notional) of FSSL and/or BPRE via borrow or buy 3–6 month put spreads (limit cost) if discounts remain >20% and distributions lack two-quarter coverage; close if discounts compress below 15% or distributions are confirmed covered.
• Construct a relative-value pair: long established CEF basket (NIE + 2 other liquid equity/balanced CEFs, equal-weight to total 3–4% exposure) vs. short new-IPO CEFs (FSSL/BPRE weighting 1–2%) — rebalance when discount differential narrows to <700 basis points or quarterly NAVs show sustained improvements.
• Use options to harvest yield: sell 2–3 month covered calls on NIE at 3–5% OTM to enhance income, and buy 3–6 month protective put spreads on any new-IPO CEF exposure to cap downside (accept defined-cost protection).